How Many Types of Breast Cancer Are There?

Getting a diagnosis can be scary, but knowing about it is a big step. Breast cancer is not just one disease. It’s a group of cancers with different traits.

You might ask how many different types of breast cancer are there. By looking into these kinds of breast cancer, we want to help you understand your options better.

Finding out what kind of cancer you have is key. It helps doctors make a plan just for you. We ask what types of breast cancers are there to give you the best care. Knowing about different kinds of breast cancer helps you make choices with your doctors.

Key Takeaways

• Breast cancer is a diverse group of diseases, not just one.
• Biological characteristics help figure out the tumor type.
• Finding the exact tumor type is important for a good treatment plan.
• Modern tests help tell the difference between fast-growing and slow-growing cancers.
• Our team offers full support to help you understand your diagnosis and move forward with confidence.

Understanding How Many Different Types of Breast Cancer Are There

Learning about the breast cancer different types can seem tough. But knowing the facts is key to good care. Doctors sort these conditions by how breast tumor cells grow and if they can spread. Spotting these breast cancer types early helps us tailor treatments just for you.

Differentiating Between Invasive and Non-Invasive Carcinomas

We tell cancers apart by if they’ve spread. Non-invasive cancers stay in the ducts or glands where they started. These are often stage 0.

Invasive cancers have broken through their walls. They can then spread to other parts of the body. Knowing this is essential for figuring out how serious the treatment needs to be.

Invasive Ductal Carcinoma: The Most Common Breast Tumor

When people ask, what is the most common type of breast cancer, the answer is invasive ductal carcinoma (IDC). It starts in the milk ducts and makes up about 70 to 80 percent of cases. It’s the most common breast tumor doctors see.

Because it’s so common, there are many ways to treat it. We look for these cells early to help our patients the most. This most common breast cancer needs a treatment plan that’s just right for you.

Invasive Lobular Carcinoma and Its Prevalence

Invasive lobular carcinoma (ILC) is the second most common, making up about 10 percent of invasive cases. It starts in the milk-producing glands, or lobules.

ILC can be tricky to find because it looks different on scans. We use special tools to track these cells. Treating ILC needs a dedicated strategy because of its unique growth.

Ductal Carcinoma in Situ: The Earliest Form of Breast Cancer

Ductal carcinoma in situ (DCIS) is the earliest stage of the disease. It makes up about 20 to 25 percent of new cases and is non-invasive. Even though it’s not spreading, it can turn into invasive different types of breast cancer.

Treating DCIS helps stop invasive disease from happening. We watch it closely and use targeted treatments to keep you healthy. Finding it early is our best way to manage these conditions.

Molecular Subtypes and Biomarker Classification

We classify breast cancer by its molecular profiles, not just where it is. This helps us understand the disease’s biological drivers. It also guides the choice of targeted therapies. By analyzing biomarkers, we tailor care to each patient, making treatments as precise as possible.

Each type of breast cancer is categorized by specific proteins. Knowing these profiles helps our team choose the best treatment for you.

Luminal A and Luminal B Subtypes

Luminal A and Luminal B are the most common types of hormone receptor-positive breast cancer. They are called hormone-dependent because they grow with estrogen or progesterone.

Luminal A tumors grow slowly and have a good prognosis. They respond well to treatments that block hormones.

Luminal B tumors grow a bit faster. They also need hormone treatments but might need more intense care.

HER2-positive Breast Cancer Characteristics

HER2-positive tumors have too much of the HER2 protein. This protein makes cells divide and grow fast.

Diagnosis can feel overwhelming, but finding this subtype is key to effective care. Treatments that block HER2 signals work well for these tumors.

These treatments have changed how we manage this condition. By targeting the biological drivers, we can achieve better results than before.

Triple-negative Breast Cancer: Challenges and Aggressiveness

Triple-negative breast cancer (TNBC) lacks estrogen, progesterone, and HER2 receptors. It’s often more aggressive because it doesn’t respond to common treatments.

TNBC makes up about 15 to 20 percent of all cases. We use special chemotherapy and immunotherapy for this subtype.

We’re committed to supporting you through treatment, no matter the subtype. We use advanced strategies to tackle the challenges of TNBC, ensuring you get the best care.

Conclusion

Breast cancer is a complex disease with many types. Each type needs its own special treatment plan. When you get diagnosed, you likely have many questions.

At Medical organization and MD Anderson Cancer Center, we focus on finding out what type of breast cancer you have. Knowing this helps doctors create a treatment plan just for you. This plan is based on your body’s unique needs.

Understanding your breast cancer type helps you work better with your healthcare team. Talking openly with your doctors is key. This way, your treatment plan fits your health goals.

We are here to support you with top-notch care and the latest medical knowledge. If you need help or want to talk to our specialists, please contact our patient advocacy team. We’re ready to help you every step of the way.

FAQ

References

National Center for Biotechnology Information. https://pubmed.ncbi.nlm.nih.gov/31513398/